View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsTecan Group 配当と自社株買い配当金 基準チェック /56Tecan Group配当を支払う会社であり、現在の利回りは2.24%で、収益によって十分にカバーされています。主要情報2.2%配当利回り1.4%バイバック利回り総株主利回り3.7%将来の配当利回り2.6%配当成長7.1%次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向61%最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesValuation Update With 7 Day Price Move • Jan 09Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €162, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 18x in the Life Sciences industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €292 per share.お知らせ • Dec 19Tecan Group AG to Report First Half, 2026 Results on Aug 11, 2026Tecan Group AG announced that they will report first half, 2026 results on Aug 11, 2026お知らせ • Dec 05Tecan Group AG, Annual General Meeting, Apr 15, 2026Tecan Group AG, Annual General Meeting, Apr 15, 2026.お知らせ • Dec 04ecan Group AG Announces Chairman of the Board of Directors Lukas Braunschweiler Will Not Stand for Re-ElectionTecan Group AG announced that Lukas Braunschweiler, Chairman of the Board of Directors and a member of the Board since 2018, will not stand for re-election.お知らせ • Dec 02Tecan Group AG (SWX:TECN) acquired Wako Automation.Tecan Group AG (SWX:TECN) acquired Wako Automation on December 1, 2025. Tecan Group AG (SWX:TECN) completed the acquisition of Wako Automation on December 1, 2025.お知らせ • Nov 17+ 1 more updateTecan Group AG Announces Departure of Tania Micki as Member of the Management BoardTecan Group AG announced that Tania Micki, member of the Management Board since February 2020, will be leaving the company to pursue an external opportunity. She will continue in her role through May 2026 to ensure a smooth transition. Tecan will nominate her successor in due time, leveraging the company’s succession planning process.お知らせ • Oct 13Tecan Reaffirms Earnings Guidance for the Year 2025Tecan reaffirmed earnings guidance for the year 2025. For the year, Tecan confirmed its full-year sales outlook, expecting sales in local currencies to be within the previously communicated range – from a low single-digit percentage decline to low single-digit percentage growth, with current trends indicating that full-year performance will be in the lower half of the range. Tecan also reiterates its mid-term outlook, anticipating a return to average organic growth rates in the mid- to high-single-digit percentage range in local currencies under normal market conditions, while continuously improving profitability. However, end markets are expected to recover gradually, so a full normalization is not anticipated in 2026. Guidance for 2026 will be provided, as usual, with the full-year 2025 results in March 2026.お知らせ • Oct 10Tecan Group AG to Report Fiscal Year 2025 Results on Mar 16, 2026Tecan Group AG announced that they will report fiscal year 2025 results on Mar 16, 2026お知らせ • Sep 13Tecan Group AG Announces Change of Leadership in the Partnering Business DivisionThe Tecan Group announced a change of leadership in its Partnering Business division. Ralf Griebel, who has served as Head of the Partnering Business division and as a member of the Management Board since April 2020, will be leaving the Company to pursue other opportunities. Monica Manotas will assume interim leadership of the Partnering Business division, taking this as an opportunity to work more closely with the business.Reported Earnings • Aug 13First half 2025 earnings released: EPS: CHF1.41 (vs CHF1.76 in 1H 2024)First half 2025 results: EPS: CHF1.41 (down from CHF1.76 in 1H 2024). Revenue: CHF439.5m (down 5.9% from 1H 2024). Net income: CHF17.9m (down 20% from 1H 2024). Profit margin: 4.1% (down from 4.8% in 1H 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Life Sciences industry in Europe.Board Change • Aug 03Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Christa Kreuzburg was the last independent director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.決済の安定と成長配当データの取得安定した配当: TENの1株当たり配当金は過去10年間安定しています。増加する配当: TENの配当金は過去10年間にわたって増加しています。配当利回り対市場Tecan Group 配当利回り対市場TEN 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (TEN)2.2%市場下位25% (DE)1.5%市場トップ25% (DE)4.6%業界平均 (Life Sciences)0.8%アナリスト予想 (TEN) (最長3年)2.6%注目すべき配当: TENの配当金 ( 2.24% ) はGerman市場の配当金支払者の下位 25% ( 1.48% ) よりも高くなっています。高配当: TENの配当金 ( 2.24% ) はGerman市場の配当金支払者の上位 25% ( 4.61% ) と比較すると低いです。株主への利益配当収益カバレッジ: TENの配当金は、合理的な 配当性向 ( 60.6% ) により、利益によって賄われています。株主配当金キャッシュフローカバレッジ: TENの 現金配当性向 ( 28.4% ) は比較的低く、配当金の支払いはキャッシュフローによって十分にカバーされています。高配当企業の発掘7D1Y7D1Y7D1YDE 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/02/02 05:51終値2026/01/23 00:00収益2025/06/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Tecan Group AG 9 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。16 アナリスト機関Harry GillisBerenbergDelphine Le LouetBernsteinSusannah LudwigBernstein13 その他のアナリストを表示
Valuation Update With 7 Day Price Move • Jan 09Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €162, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 18x in the Life Sciences industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €292 per share.
お知らせ • Dec 19Tecan Group AG to Report First Half, 2026 Results on Aug 11, 2026Tecan Group AG announced that they will report first half, 2026 results on Aug 11, 2026
お知らせ • Dec 05Tecan Group AG, Annual General Meeting, Apr 15, 2026Tecan Group AG, Annual General Meeting, Apr 15, 2026.
お知らせ • Dec 04ecan Group AG Announces Chairman of the Board of Directors Lukas Braunschweiler Will Not Stand for Re-ElectionTecan Group AG announced that Lukas Braunschweiler, Chairman of the Board of Directors and a member of the Board since 2018, will not stand for re-election.
お知らせ • Dec 02Tecan Group AG (SWX:TECN) acquired Wako Automation.Tecan Group AG (SWX:TECN) acquired Wako Automation on December 1, 2025. Tecan Group AG (SWX:TECN) completed the acquisition of Wako Automation on December 1, 2025.
お知らせ • Nov 17+ 1 more updateTecan Group AG Announces Departure of Tania Micki as Member of the Management BoardTecan Group AG announced that Tania Micki, member of the Management Board since February 2020, will be leaving the company to pursue an external opportunity. She will continue in her role through May 2026 to ensure a smooth transition. Tecan will nominate her successor in due time, leveraging the company’s succession planning process.
お知らせ • Oct 13Tecan Reaffirms Earnings Guidance for the Year 2025Tecan reaffirmed earnings guidance for the year 2025. For the year, Tecan confirmed its full-year sales outlook, expecting sales in local currencies to be within the previously communicated range – from a low single-digit percentage decline to low single-digit percentage growth, with current trends indicating that full-year performance will be in the lower half of the range. Tecan also reiterates its mid-term outlook, anticipating a return to average organic growth rates in the mid- to high-single-digit percentage range in local currencies under normal market conditions, while continuously improving profitability. However, end markets are expected to recover gradually, so a full normalization is not anticipated in 2026. Guidance for 2026 will be provided, as usual, with the full-year 2025 results in March 2026.
お知らせ • Oct 10Tecan Group AG to Report Fiscal Year 2025 Results on Mar 16, 2026Tecan Group AG announced that they will report fiscal year 2025 results on Mar 16, 2026
お知らせ • Sep 13Tecan Group AG Announces Change of Leadership in the Partnering Business DivisionThe Tecan Group announced a change of leadership in its Partnering Business division. Ralf Griebel, who has served as Head of the Partnering Business division and as a member of the Management Board since April 2020, will be leaving the Company to pursue other opportunities. Monica Manotas will assume interim leadership of the Partnering Business division, taking this as an opportunity to work more closely with the business.
Reported Earnings • Aug 13First half 2025 earnings released: EPS: CHF1.41 (vs CHF1.76 in 1H 2024)First half 2025 results: EPS: CHF1.41 (down from CHF1.76 in 1H 2024). Revenue: CHF439.5m (down 5.9% from 1H 2024). Net income: CHF17.9m (down 20% from 1H 2024). Profit margin: 4.1% (down from 4.8% in 1H 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Life Sciences industry in Europe.
Board Change • Aug 03Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Christa Kreuzburg was the last independent director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.